Cybin (HELP) EBITDA (2020 - 2024)
Cybin (HELP) reported EBITDA of -$12.9 million for Q4 2024, up 38.68% on a YoY basis from -$9.3 million in Q1 2024, and up 69.6% quarter-over-quarter from -$42.5 million in Q3 2024.
Cybin (HELP) EBITDA (2020 - 2024) Analysis & Trends
Cybin has reported EBITDA for 5 years, with the latest figure at -$12.9 million in Q4 2024.
- For the quarter ending Q4 2024, EBITDA rose 38.68% year-over-year to -$12.9 million; the trailing twelve-month figure through Dec 2024 stood at -$88.2 million (down 298.33% YoY), and the FY2023 full-year result was -$18.8 million, changed N/A from the prior year.
- EBITDA for Q4 2024 stood at -$12.9 million, up from -$42.5 million in the prior quarter.
- The five-year high for EBITDA was $18.7 million in Q1 2023, with the low at -$42.5 million in Q3 2024.
- Historically, EBITDA has averaged -$9.6 million across 5 years, with a median of -$9.8 million in 2023.
- Annual changes were most pronounced in 2021 — EBITDA slumped 580.22% — and 2022, when it jumped 42.63%.
- Cybin's EBITDA stood at -$8.8 million in 2020, then slumped by 56.99% to -$13.8 million in 2021, then soared by 33.87% to -$9.1 million in 2022, then plunged by 131.79% to -$21.1 million in 2023, then jumped by 38.68% to -$12.9 million in 2024.
- The last three EBITDA figures came in at -$12.9 million (Q4 2024), -$42.5 million (Q3 2024), and -$11.6 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -12.92 Mn |
| Sep 30, 2024 | -42.51 Mn |
| Jun 30, 2024 | -11.64 Mn |
| Dec 31, 2023 | -21.08 Mn |
| Sep 30, 2023 | -9.78 Mn |
| Jun 30, 2023 | -9.93 Mn |
| Feb 28, 2023 | 18.65 Mn |
| Dec 31, 2022 | -9.09 Mn |
| Sep 30, 2022 | -7.79 Mn |
| May 31, 2022 | 6.32 Mn |
| Dec 31, 2021 | -13.75 Mn |
| Sep 30, 2021 | -13.58 Mn |
| Jun 30, 2021 | -12.54 Mn |
| Mar 31, 2021 | -9.33 Mn |
| Dec 31, 2020 | -8.76 Mn |
| Sep 30, 2020 | -2.00 Mn |
| Jun 30, 2020 | -3.15 Mn |